Empowered Funds’s Pacira BioSciences PCRX Stock Holding History

Empowered Funds’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.08M	Sell	200,073 -76,703	-28%	-$1.81M	0.03%	702
2026 Q1	$6.26M	Buy	+276,776	New	+$6.15M	0.04%	554
2025 Q4	–	Sell	-223,438	Closed	-$5.76M	–	1654
2025 Q3	$5.76M	Sell	223,438 -15,535	-7%	-$382K	0.06%	436
2025 Q2	$5.71M	Buy	238,973 +4,744	+2%	+$120K	0.06%	401
2025 Q1	$5.82M	Buy	234,229 +4,744	+2%	+$114K	0.08%	336
2024 Q4	$4.32M	Buy	229,485 +11,149	+5%	+$196K	0.06%	419
2024 Q3	$3.29M	Buy	+218,336	New	+$3.73M	0.05%	499

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's PCRX Position: Q2 2026 in Review

Empowered Funds reduced its Pacira BioSciences (PCRX) stake by 28% in Q2 2026, selling an estimated $1.81M and leaving 200,073 shares worth $5.08M. The position accounts for 0.03% of the portfolio, ranked #702.

Empowered Funds first reported a position in PCRX in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.26M in Q1 2026. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Empowered Funds held 200,073 shares of Pacira BioSciences worth $5.08M as of Q2 2026.
Empowered Funds sold 76,703 Pacira BioSciences shares in Q2 2026, an estimated $1.81M.
Pacira BioSciences made up 0.03% of Empowered Funds's portfolio in Q2 2026, its #702 holding.
Empowered Funds first reported a position in Pacira BioSciences in Q3 2024 and has held it in 7 quarters since.
Empowered Funds's Pacira BioSciences position peaked at $6.26M in Q1 2026.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.